Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

Muddying the waters by overlooking treatment modality

Nature Reviews Clinical Oncology volume 11, pages 305–307 (2014)Cite this article

Subjects

Although large, population-based studies are a powerful tool for elucidating real-world outcomes and uncommon events, confounding factors must be tightly controlled. A recent report from Nam and coauthors has neglected such a confounding factor and, therefore, stands in need of further study to clarify the findings.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Nam, R. K. et al. Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study. Lancet Oncol. 15, 223–231 (2014).

    Article  Google Scholar 

  2. Sanda, M. G. et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N. Engl. J. Med. 358, 1250–1561 (2008).

    Article  CAS  Google Scholar 

  3. Wong, W. W. et al. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy. Cancer 115, 5596–5606 (2009).

    Article  CAS  Google Scholar 

  4. Mohammed, N. et al. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 82, 204–212 (2012).

    Article  Google Scholar 

  5. Jüni, P. et al. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 364, 2021–2029 (2004).

    Article  Google Scholar 

  6. Vickers, A. J. et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J. Natl Cancer Inst. 99, 1171–1177 (2007).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Mount Sinai Roosevelt Hospital, 1000 10th Avenue, New York, 10019, NY, USA

    Ronald D. Ennis & S. Aidan Quinn

Authors
  1. Ronald D. Ennis
    View author publications

    Search author on:PubMed Google Scholar

  2. S. Aidan Quinn
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Ronald D. Ennis.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ennis, R., Quinn, S. Muddying the waters by overlooking treatment modality. Nat Rev Clin Oncol 11, 305–307 (2014). https://doi.org/10.1038/nrclinonc.2014.52

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrclinonc.2014.52

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing